Godrej Agrovet Limited has informed the Exchange about Transcript
GODREJAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godrej Agrovet posted Q1 FY26 consolidated revenue of Rs. 2,614 crore, up 11% YoY, with profit before tax rising 25% to Rs. 188 crore. Vegetable Oil was the standout, with fresh fruit bunch arrivals up 50% YoY at 178k tons and oil extraction ratio at 18.37%. Astec LifeSciences revenue grew 31% YoY and management reiterated an FY26 EBITDA break-even target with Rs. 500 crore turnover ambition. The company also announced a leadership change, with Sunil Kataria set to take over as MD from Balram Yadav. Management maintained early-teens top-line growth guidance for FY26 and guided for crop protection steady-state EBIT margins of 28-30%.
Positive signals from strong Q1 profit growth (25% YoY) and upbeat oil palm outlook, partly offset by pressure in crop protection from erratic rainfall and weak PYNA herbicide sales. Clean-up of group structure (100% ownership of Godrej Foods and Creamline Dairy) and debt repayment via the rights issue strengthen the balance sheet, while the management transition is a key near-term watchpoint for shareholders.